Transaction expected to close in the first quarter of 2024, subject to customary closing conditionsMichele Manto, Galapagos’ Chief Commercial Officer, to join Alfasigma Mechelen, Belgium; 02.
Galapagos NV (GLPG), a bio-pharmaceutical company, Tuesday said it entered into a deal to sell its Jyseleca business to Italian pharma company Alfasigma. As per the terms of the agreement, Michele Manto the Chief Commercial Officer of the company has resigned and will be joining Alfasigma in the same capacity.
Galapagos and Alfasigma S.p.A. announced that they have signed an agreement to transfer Galapagos? Jyseleca® business to Alfasigma, marking a significant milestone in Galapagos? transformation into.
Operator: Good day, and thank you for standing by. Welcome to the Galapagos Q3 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.